P
41.30
0.29 (0.71%)
| Previous Close | 41.01 |
| Open | 40.80 |
| Volume | 1,574,607 |
| Avg. Volume (3M) | 874,230 |
| Market Cap | 6,536,649,216 |
| Price / Earnings (TTM) | 26.65 |
| Price / Earnings (Forward) | 15.55 |
| Price / Sales | 1.00 |
| Price / Book | 5.58 |
| 52 Weeks Range | |
| Earnings Date | 10 Aug 2026 |
| Profit Margin | 2.59% |
| Operating Margin (TTM) | 0.07% |
| Diluted EPS (TTM) | 0.610 |
| Quarterly Revenue Growth (YOY) | 29.10% |
| Quarterly Earnings Growth (YOY) | 30.70% |
| Total Debt/Equity (MRQ) | 469.36% |
| Current Ratio (MRQ) | 1.71 |
| Operating Cash Flow (TTM) | 99.08 M |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Bullish | Bullish |
| Medical Care Facilities (Global) | Bullish | Bullish | |
| Stock | PACS Group, Inc. | Bullish | Bullish |
AIStockmoo Score
0.5
| Analyst Consensus | 3.0 |
| Insider Activity | NA |
| Price Volatility | -0.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 2.0 |
| Average | 0.50 |
|
PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Core |
| % Held by Insiders | 72.29% |
| % Held by Institutions | 29.86% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Defilade Capital Management, L.P. | 31 Dec 2025 | 1,145,485 |
| 8 Knots Management, Llc | 31 Dec 2025 | 610,070 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 52.00 (RBC Capital, 25.91%) | Buy |
| Median | 44.00 (6.54%) | |
| Low | 42.00 (Oppenheimer, 1.70%) | Buy |
| Average | 46.00 (11.38%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 36.40 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Oppenheimer | 04 Mar 2026 | 42.00 (1.69%) | Buy | 36.35 |
| UBS | 04 Mar 2026 | 44.00 (6.54%) | Buy | 36.35 |
| RBC Capital | 27 Feb 2026 | 52.00 (25.91%) | Buy | 36.51 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |